0001209191-14-071540.txt : 20141126 0001209191-14-071540.hdr.sgml : 20141126 20141126165534 ACCESSION NUMBER: 0001209191-14-071540 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141124 FILED AS OF DATE: 20141126 DATE AS OF CHANGE: 20141126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001446847 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043404176 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Higgins Michael J CENTRAL INDEX KEY: 0001478521 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34620 FILM NUMBER: 141254286 MAIL ADDRESS: STREET 1: C/O IRONWOOD PHARMACEUTICALS INC STREET 2: 320 BENT STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-11-24 0 0001446847 IRONWOOD PHARMACEUTICALS INC IRWD 0001478521 Higgins Michael J C/O IRONWOOD PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Operating Officer Class B Common Stock 2014-11-24 4 M 0 70898 1.56 A 370898 D Class B Common Stock 2014-11-24 4 S 0 70898 13.75 D 300000 D Employee Stock Option (Right to Buy) 1.56 2014-11-24 4 M 0 70898 0.00 D 2016-03-14 Class B Common Stock 70898 129102 D In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.64 to $13.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The option vests upon the earlier of (i) the issuer's achievement of certain regulatory and commercial milestones and (ii) January 1, 2016. Upon achievement of a regulatory milestone on October 24, 2011 and a commercial milestone on December 21, 2012, the option vested as to 100,000 and 50,000 shares, respectively. /s/ Halley E. Gilbert Attorney-in-Fact 2014-11-26